Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.
about
Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsCarboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomesIdentification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirusKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesKaposi's Sarcoma Herpesvirus Genome PersistenceActivation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusThe Modulation of Apoptotic Pathways by GammaherpesvirusesCell Cycle Regulatory Functions of the KSHV Oncoprotein LANAKSHV Genome Replication and MaintenanceThe Role of Gammaherpesviruses in Cancer PathogenesisA Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA ProteinsMolecular Basis for Oligomeric-DNA Binding and Episome Maintenance by KSHV LANAAltering murine leukemia virus integration through disruption of the integrase and BET protein family interactionThe Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous ProteinsBRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBET domain co-regulators in obesity, inflammation and cancerGrowth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4.Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistenceLANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complexHHV-8 encoded LANA-1 alters the higher organization of the cell nucleus.Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tailstBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation.Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latencyE mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.Chromatin organization of gammaherpesvirus latent genomes.Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathwayKaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterEpidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation.Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusLatency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
P2860
Q24295275-59F035BD-6CB1-43F9-9CC7-AE9C4B4B56ADQ24520588-24C3A5D9-66AB-4458-B5E4-1D2D7286EE6CQ24527215-9E50B728-8A1A-471E-A0EE-FD9169A3B48AQ24531182-D5C44AF9-A4CB-4DCA-8C29-747B5D241CECQ24538878-165F7C89-FE7F-49E6-94F4-3B4627F86F67Q24646461-CBA82D01-4A0B-4FB3-BA30-5AC0628E8B75Q24673761-EA455A26-DC18-46D3-A013-455349DBD07BQ26738483-8BFD7BBC-64E6-4109-B9D7-BDCE8D391345Q26743368-4DCF081E-D8BE-4203-9636-6EA2E8E87ECDQ26747452-05CF3D14-B22A-4F7A-8083-09059CAABD18Q26749612-3C1C931B-D9BF-4D1B-94E6-00F8F26E6322Q26766437-3493625A-E1B9-45D5-8F68-AF66205D4688Q26767186-109C1A52-AF43-4CA3-BF87-5EE1E0156BCFQ27680409-DC2F79FB-6E3E-497A-A5AE-CDEF5A38F1D1Q27680411-2B66E5A2-871E-4A01-80B3-81433A06E38CQ27682160-15144023-A383-4759-BEF2-D91FD021B89EQ28073961-E4A8A26F-0D2C-48ED-BF1D-5D36210E1751Q28116760-CBF6CCA7-796F-4DEE-B519-D8FB0BD159CEQ28269301-A4DA287D-F987-411F-A7D6-FE90FE94CA5EQ28508455-9F29F276-062E-427F-91C2-6BE803AFFAADQ28533244-563A3639-5E47-4E58-BCA7-7C3DE59FE491Q28540872-515CA1D0-A261-47E1-AB78-A9D8F78314C5Q30479353-A31D01A0-1394-47E8-9254-745F82735E52Q33221441-0CCBFE0E-B2FB-4D8D-9190-DD095FD067C2Q33282107-C8D9195F-EBD6-4D8E-BD9F-CCB411182655Q33298555-E0F3807D-4591-4CB9-B5CC-B1495DF048CEQ33588029-E46C1989-7A98-4072-8A9A-936B26AB9F9DQ33632932-9AD47BAE-B476-4C36-B50B-71F88CF0E9B0Q33673921-BA989D4D-07CF-435B-B8C4-F9A7B944CBDFQ33729584-C9109C07-B5E0-4AFF-AF1E-DEFD06E61B4CQ33737793-25C17A5C-911B-4256-A73A-1C4144A736C9Q33744019-FD81F527-74C0-4536-B467-2601C704739EQ33748042-F72639BF-78F4-488D-9EDE-C846275D25EFQ33772234-08106017-5472-4BA5-A1D3-DF0055023E32Q33834414-F1977534-FE00-4D8D-BE86-9AA8C76BCC59Q33835021-4E2B6E5E-9DBE-4543-B85D-75E502CC5B49Q33838228-3BA352AE-B15C-4F13-9210-E793C709F9A8Q33851443-805023D9-BD6C-4C91-9512-686055176879Q33853499-690AA6EF-52EE-4DAB-BD4B-930BA92BE6F1Q33854704-77A75847-B1C1-40BD-8049-5E7A1ACF3232
P2860
Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@ast
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@en
type
label
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@ast
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@en
prefLabel
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@ast
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@en
P2093
P2860
P1433
P1476
Latent nuclear antigen of Kapo ...... e sterile homeotic (fsh) gene.
@en
P2093
G R Simpson
S Mittnacht
T F Schulz
P2860
P304
P577
1999-12-01T00:00:00Z